Paw Privileges
Evidence DatabaseSaved evidence
Claim evidence

Adjunctive anti-inflammatory effect in canine OA

Grade CLimited or mixed evidenceSave claim
Ingredient: Turmeric / Curcumin · botanical

Plain-language summary

Bioavailability is the main limit; results are mixed and formulation-dependent.

About the ingredient

What it is

Yellow root traditionally used for inflammation.

Why it's used

Marketed for joint and general wellness.

Also known as: Turmeric, Curcuma longa

Cited studies (5)

Canine studies
  • Antitumor Effect of Curcumin, D6 Turmeric, and Hydrochloride Mitoxantrone on Canine and Human Urothelial Cancer Cells.
    Silva TOD, Calheiros LGRM, Barbosa F, Morrone FB, Rockenbach L, Lainetti PF, Leis Filho AF, Carvalho M, Fonseca-Alves CE, Laufer Amorim R · Animals : an open access journal from MDPI · 2025
    Study summary
    Very limited quality
    Design score 2/11
    Design
    Journal Article
    Species
    dog
    Sample size
    Not reported
    Duration
    Not reported
    Controls / blinding
    Not reported
    Funding
    Not reported
    Strengths
    • Conducted in dogs
    Limitations
    • Sample size not recorded
    • No control group recorded
    • Study duration not recorded

    Relevance to this claim: Ingredient-level evidence for Turmeric / Curcumin

  • Turmeric and Curcumin-Health-Promoting Properties in Humans versus Dogs.
    Kępińska-Pacelik J, Biel W · International journal of molecular sciences · 2023
    Study summary
    Very limited quality
    Design score 2/11
    Design
    Journal Article; Review
    Species
    dog
    Sample size
    Not reported
    Duration
    Not reported
    Controls / blinding
    Not reported
    Funding
    Not reported
    Strengths
    • Conducted in dogs
    Limitations
    • Sample size not recorded
    • No control group recorded
    • Study duration not recorded

    Relevance to this claim: Ingredient-level evidence for Turmeric / Curcumin

  • Study summary
    Moderate quality
    Design score 6/11
    Design
    Randomized double-blind placebo-controlled clinical trial
    Species
    DOG
    Sample size
    n = 42
    Duration
    Not reported
    Controls / blinding
    Not reported
    Funding
    Not reported
    Strengths
    • Randomized trial design
    • Conducted in dogs
    • Moderate sample (n=42)
    Limitations
    • No control group recorded
    • Study duration not recorded

    Outcome: Pain on manipulation improved, but objective ground-reaction forces and most other veterinary measures did not differ.

    Relevance to this claim: Canine evidence supports possible benefit of a standardized curcuminoid combination, but not unstandardized turmeric root powder in isolation.

  • Bioavailable curcumin formulation in canine OA
    Canadian Journal of Animal Science · 2016
    Study summary
    Moderate quality
    Design score 6/11
    Design
    RCT
    Species
    dog
    Sample size
    Not reported
    Duration
    Not reported
    Controls / blinding
    Controlled comparison group (per recorded study design)
    Funding
    Not reported
    Strengths
    • Randomized trial design
    • Conducted in dogs
    Limitations
    • Sample size not recorded
    • Study duration not recorded

    Outcome: Modest improvement in mobility scores

  • Effects and synergy of feed ingredients on canine neoplastic cell proliferation.
    Levine CB, Bayle J, Biourge V, Wakshlag JJ · BMC veterinary research · 2016
    Study summary
    Very limited quality
    Design score 2/11
    Design
    Journal Article
    Species
    dog
    Sample size
    Not reported
    Duration
    Not reported
    Controls / blinding
    Not reported
    Funding
    Not reported
    Strengths
    • Conducted in dogs
    Limitations
    • Sample size not recorded
    • No control group recorded
    • Study duration not recorded

    Relevance to this claim: Ingredient-level evidence for Turmeric / Curcumin

Products in our catalog with Turmeric / Curcumin (9)

Educational information only. Not veterinary advice. Grades reflect published dog research and reviewer consensus, not marketing.